story of the week
Chronic Immune-Related AEs After Adjuvant Anti–PD-1 for High-Risk Resected Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
JAMA Oncol 2021 Mar 25;[EPub Ahead of Print], JR Patrinely, R Johnson, AR Lawless, P Bhave, A Sawyers, M Dimitrova, HL Yeoh, M Palmeri, F Ye, R Fan, EJ Davis, S Rapisuwon, GV Long, A Haydon, I Osman, JM Mehnert, MS Carlino, RJ Sullivan, AM Menzies, DB JohnsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.